Bitwise Announces Monthly Distributions for IMST, ICOI, and IMRA
SAN FRANCISCO–(BUSINESS WIRE)–Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option... Read more.
ARBA Retail Systems: Powering the Future of Retail with Artificial Intelligence
CHICAGO–(BUSINESS WIRE)–At ARBA Retail Systems, we’re leading the way in transforming retail technology with the power of AI and artificial intelligence.... Read more.
Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025
– Zanzalintinib in combination with nivolumab demonstrated an objective response rate of 63% and a disease control rate of 90% – – Additional results from... Read more.
KBRA Assigns Preliminary Ratings to BX 2025-LUNR
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA announces the assignment of preliminary ratings to four classes of BX 2025-LUNR, a CMBS single-borrower... Read more.
Erie’s Public Schools and Zurn Elkay Water Solutions Announce Donation for Cleaner, Healthier, Safer Drinking Water
This summer Erie’s Public Schools (EPS) will install 50 donated Elkay filtered bottle filling stations in nine elementary schools and convert all faucets at the... Read more.
Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting
Studies include nearly 25,000 patients across multiple indications, showcasing the clinical impact of Signatera Breast: 8 accepted abstracts (4 oral presentations),... Read more.
Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
CAMBRIDGE, England, & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated... Read more.
Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline
PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #ASCO—Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology portfolio... Read more.
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025
MADISON, Wis.–(BUSINESS WIRE)–Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it will... Read more.
Flatiron Health Announces Research to Be Presented at ASCO 2025
Flatiron’s 2025 ASCO research showcases the power of longitudinal, real-world oncology data and innovative AI-driven methodologies to generate actionable evidence,... Read more.